FDA Drug Delivery Systems Workshop Slated For July 8
Executive Summary
FDA is soliciting feedback on regulatory challenges posed by novel drug and biologics delivery systems, and steps the agency can take to ease the regulatory pathway
You may also be interested in...
FDA Combo Approvals Could Follow Drug-Eluting Stent Template
FDA should use its approval of drug-eluting stents as the template for combination product approvals, attendees recommended at FDA's drug delivery workshop July 8 in Bethesda, Md
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011